mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.5 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.5 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |